What does CUSIP 81728J109 represent in this 13F holders report?

CUSIP 81728J109 is the security identifier for SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value used to aggregate holder disclosures.

How many institutions held SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value in Q2 2024?

47 institutional investors reported SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value for Q2 2024. Use the holders table for investor-level position and value details.

Sensus Healthcare, Inc. - Common Stock, $0.01 par value (SRTS)

CUSIP: 81728J109

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.01 par value
Total 13F shares: 3,273,489
Total 13F value: $17,552,838
Share change: +778,733
Put/Call ratio: 0%
SEC-reported price per share: $5.33
Number of holders: 47
Value change: +$4,434,599
Number of buys: 29
Number of sells: 19
Shares outstanding: 16,385,263

Security key

81728J109

Report period

Q2 2024

Institutions

Top holders

SRTS full security history Ownership snapshot Full 13F holder table Sensus Healthcare, Inc. SEC filings Sensus Healthcare, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SRTS - Sensus Healthcare, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Joseph C. Sardano

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

31 Mar 2024

13D/G 3/4/5 13F Lead comparable stake: 7.1% 13D/G row: Joseph C. Sardano Showing 1-6 of 15 holder rows.

Quick read

Joseph C. Sardano leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Joseph C. Sardano's linked filing trail.

Comparable ownership Top 5

Joseph C. Sardano 7.1%

Magdalena Martinez 0.07%

VANGUARD GROUP INC 4.8%

RENAISSANCE TECHNOLOGIES LLC 1.8%

PERRITT CAPITAL MANAGEMENT INC 0.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Joseph C. Sardano	13D/G 13D/G	7.1%	— 1,175,293 shares	$0	14 Sep 2023
Magdalena Martinez	3/4/5 CHIEF OPERATING OFFICER 3/4/5	0.07%	$47,090 12,013 shares	—	19 Dec 2023
VANGUARD GROUP INC	13F Company 13F	4.8%	$2,960,398 779,052 shares	—	31 Mar 2024
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	1.8%	$1,107,000 291,240 shares	—	31 Mar 2024
PERRITT CAPITAL MANAGEMENT INC	13F Company 13F	0.8%	$496,227 130,586 shares	—	31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.78%	$485,069 127,617 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,273,489

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %